Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Ergomed industry appoints Roy Ovel as Chief Commercial Officer

Monday, 1st April 2019
Pharmaceutical services provider Ergomed industry appointed Roy Ovel as Chief Commercial Officer with immediate effect.

Roy would join Ergomed's Executive team and be responsible for global sales and business development activities across the Company's full services offering. This would include a focus on the benefits to customers of bringing together Ergomed's expertise in pharmacovigilance and orphan drug development.

Roy brings to Ergomed over 30 years' experience in international business development with a number of the leading global CROs. This had included roles with larger CROs such as ICON, TFS and Worldwide Clinical Trials as well as with local, specialist CROs.

At TFS International, Mr Ovel was responsible for global sales and marketing for more than four years, including leadership of the global marketing team.

At 8:18am: (LON:ERGO) Ergomed Plc share price was +1p at 167.5p

Story provided by

Related Shares: Ergomed

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.